A. Mutnick

发表

Pharmacist- versus physician-obtained medication histories.

Todd A. Reeder, A. Mutnick, 2008, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

A Cost-Effectiveness Analysis of Stress Ulcer Prophylaxis

A. Mutnick, K. Schupp, L. M. Schrand, 2003, The Annals of pharmacotherapy.

A cost analysis comparing erythropoietin and red cell transfusions in the treatment of anemia of prematurity

J. Widness, R. Strauss, A. Mutnick, 1995, Transfusion.

Nicotinic Acid: A Review of Its Clinical Use in the Treatment of Lipid Disorders

F. Sacks, J. Figge, A. Mutnick, 1988, Pharmacotherapy.

Antimicrobial susceptibility patterns of beta-hemolytic and viridans group streptococci: report from the SENTRY Antimicrobial Surveillance Program (1997-2000).

Ronald N. Jones, P. Rhomberg, A. Mutnick, 2002, Diagnostic microbiology and infectious disease.

Impact of Modified Nonmeningeal Streptococcus pneumoniae Interpretive Criteria (NCCLS M100-S12) on the Susceptibility Patterns of Five Parenteral Cephalosporins: Report from the SENTRY Antimicrobial Surveillance Program (1997 to 2001)

Ronald N. Jones, A. Mutnick, D. Varnam, 2002, Journal of Clinical Microbiology.

Antimicrobial usage and resistance trend relationships from the MYSTIC Programme in North America (1999-2001).

Ronald N. Jones, P. Rhomberg, A. Mutnick, 2004, The Journal of antimicrobial chemotherapy.

Implementing guidelines for the institutional use of factor VIIa (recombinant): a multidisciplinary solution.

A. Mutnick, B. G. Macik, Kathlene A Degregory, 2006, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

Linezolid Resistance since 2001: SENTRY Antimicrobial Surveillance Program

Ronald N. Jones, A. Mutnick, V. Enne, 2003, The Annals of pharmacotherapy.

Pathogen of occurrence and susceptibility patterns associated with pneumonia in hospitalized patients in North America: results of the SENTRY Antimicrobial Surveillance Study (2000).

Ronald N. Jones, D. Hoban, A. Mutnick, 2003, Diagnostic microbiology and infectious disease.

Dopamine versus Dobutamine: Are All the Facts There?

E. Drea, A. Mutnick, B. Szymusiak-Mutnick, 1990, Pharmacotherapy.

Contemporary evaluation of the in vitro activity and spectrum of cefdinir compared with other orally administered antimicrobials tested against common respiratory tract pathogens (2000-2002).

Ronald N. Jones, T. Fritsche, A. Mutnick, 2003, Diagnostic microbiology and infectious disease.

In vitro evaluation of BAL9141, a novel parenteral cephalosporin active against oxacillin-resistant staphylococci.

Ronald N. Jones, A. Mutnick, D. Biedenbach, 2002, The Journal of antimicrobial chemotherapy.

Ventricular fibrillation and anoxic encephalopathy secondary to astemizole overdose

A. Mutnick, T. Burke, 1993, The Annals of pharmacotherapy.

A Cost-Benefit Analysis of RSV Prophylaxis in High-Risk Infants

E. Bell, A. Mutnick, L. M. Schrand, 2001, The Annals of pharmacotherapy.

Authors' Reply

E. Drea, A. Mutnick, 1990 .

Contrast Media Adverse Reactions

E. Drea, A. Mutnick, 1989, DICP : the annals of pharmacotherapy.

Treatment of Cyanide and Thiocyanate Toxicity Secondary to Sodium Nitroprusside

A. Mutnick, T. Burke, 1994 .

ASHP guidelines on documenting pharmaceutical care in patient medical records.

B. Erstad, D. Malyuk, R. Shane, 2003, American Journal of Health-System Pharmacy.

CANCER Resistance Surveillance Program: Initial Results from Hematology–Oncology Centers in North America

Ronald N. Jones, A. Mutnick, J. T. Kirby, 2003, The Annals of pharmacotherapy.

Spectrum and potency evaluation of a new oxazolidinone, linezolid: report from the SENTRY Antimicrobial Surveillance Program, 1998-2000.

Ronald N. Jones, J. Turnidge, A. Mutnick, 2002, Diagnostic microbiology and infectious disease.

Emerging Antimicrobial Resistances Among Proteus mirabilis in Europe: Report from the MYSTIC Program (1997-2001)

A. Mutnick, P. Turner, R. Jones, 2002, Journal of chemotherapy.

Emerging resistance among Proteus mirabilis isolates in Europe : report from the MYSTIC program ( 1997-2001 )

A. Mutnick, P. Turner, R. Jones, 2002 .

Geographic variations and trends in antimicrobial resistance among Enterococcus faecalis and Enterococcus faecium in the SENTRY Antimicrobial Surveillance Program (1997-2000).

Ronald N. Jones, A. Mutnick, D. Biedenbach, 2003, Diagnostic microbiology and infectious disease.

Application of Decision Analysis in Antibiotic Formulary Choices

A. Mutnick, B. Szymusiak-Mutnick, 1994 .

Recombinant human erythropoietin vs transfusions in the treatment of anemia of prematurity. A cost-benefit analysis.

J. Widness, R. Strauss, T. Shireman, 1994, Archives of pediatrics & adolescent medicine.

Clinical Pharmacist Intervention in an Extended Care Facility

A. Mutnick, L. N. Swanson, 1980 .

Antimicrobial activity of LB10827, a new orally administered cephalosporin, tested against Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae.

R. Jones, A. Mutnick, M. Beach, 2003, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Occurrence and antimicrobial susceptibility patterns of pathogens isolated from skin and soft tissue infections: report from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 2000).

Ronald N. Jones, R. Rennie, A. Mutnick, 2003, Diagnostic microbiology and infectious disease.

Geographic variations in garenoxacin (BMS284756) activity tested against pathogens associated with skin and soft tissue infections: report from the SENTRY Antimicrobial Surveillance Program (2000).

Ronald N. Jones, M. Pfaller, A. Mutnick, 2002, Diagnostic microbiology and infectious disease.

Drug allergy assessment at a university hospital and clinic.

A. Mutnick, T. Burke, J. D. Pilzer, 1996, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

Sumatriptan: A New Treatment for Migraine and Cluster Headaches

A. Mutnick, M. B. Ross, Michelle M. Mulcahy, 1993, Journal of Pharmacy Technology.

Clinical Pharmacy Education in New England: A Report of the Whispering Pines Conference

S. Fish, A. Mutnick, A. Cardoni, 1989, DICP : the annals of pharmacotherapy.

Comprar Comprehensive Pharmacy Review | Alan H. Mutnick | 9781451175745 | Lippincott Williams & Wilkins

L. Shargel, A. Mutnick, 2012 .

Medication use evaluation: a work in progress.

A. Mutnick, L. M. Schrand, K. Behmer‐Miller, 2000, Pharmacy practice management quarterly.

Locally derived clinical practice guidelines using a decision analysis model.

A. Mutnick, B. Szymusiak-Mutnick, 1996, AACN clinical issues.

Cimetidine-Associated Adverse Reaction

A. Mutnick, W. Lam, Edward J. Drea, 1990, DICP : the annals of pharmacotherapy.

Consumer-Driven Health Care: Implications for Providers, Payers, and Policymakers

A. Mutnick, 2004 .

University of Iowa Hospital and Clinics: outcomes management.

M. Titler, B. Rakel, A. Mutnick, 1999, Nursing administration quarterly.

Cost savings and avoidance from clinical interventions.

A. Mutnick, A H Mutnick, K J Sterba, 1997, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.